Business Standard

Glenmark, Merck ink euro 190mn drug deal

Image

Our Web Bureau Mumbai
Glenmark, Merck ink euro 190mn drug deal
Our Web Bureau / Mumbai October 17, 2006
Glenmark Pharmaceuticals S.A., the Switzerland-based subsidiary of Glenmark, and Merck KGaA have entered into an agreement under which Merck KGaA will develop, register and commercialize Glenmark

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 17 2006 | 6:58 PM IST

Explore News